CRZBF(CRZBF)
CRZBF
No analyst ratings available
No analyst price targets available for CRZBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $13.21B | $14.16B | $15.06B | $15.31B | $16.62B |
| Low | $12.98B | $13.71B | $14.69B | $14.93B | $16.21B |
| High | $13.35B | $14.44B | $15.29B | $15.55B | $16.88B |
| EBITDA Avg | $2.87B | $3.07B | $3.27B | $3.32B | $3.61B |
| Low | $2.82B | $2.97B | $3.19B | $3.24B | $3.52B |
| High | $2.90B | $3.13B | $3.32B | $3.37B | $3.66B |
| EBIT Avg | $2.15B | $2.30B | $2.45B | $2.49B | $2.70B |
| Low | $2.11B | $2.23B | $2.39B | $2.43B | $2.64B |
| High | $2.17B | $2.35B | $2.49B | $2.53B | $2.74B |
| Net Income Avg | $3.48B | $4.25B | $5.17B | $5.28B | $6.70B |
| Low | $3.36B | $4.12B | $5.00B | $5.11B | $6.49B |
| High | $3.55B | $4.34B | $5.27B | $5.39B | $6.84B |
| EPS Avg | $3.08 | $3.77 | $4.59 | $4.68 | $5.95 |
| Low | $2.99 | $3.65 | $4.44 | $4.53 | $5.75 |
| High | $3.15 | $3.85 | $4.68 | $4.78 | $6.07 |
| Analysts (Rev / EPS) | 12 / 1 | 12 / 1 | 6 / 1 | 11 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $3.34B | $3.44B | $3.57B |
| Low | $3.33B | $3.44B | $3.57B |
| High | $3.34B | $3.44B | $3.57B |
| EBITDA Avg | $724M | $746M | $774M |
| Low | $723M | $746M | $773M |
| High | $725M | $747M | $775M |
| EBIT Avg | $542M | $559M | $580M |
| Low | $542M | $559M | $579M |
| High | $543M | $560M | $581M |
| Net Income Avg | $1.03B | $970M | $1.23B |
| Low | $1.03B | $969M | $1.23B |
| High | $1.03B | $971M | $1.23B |
| EPS Avg | $0.79 | $0.74 | $0.95 |
| Low | $0.79 | $0.74 | $0.94 |
| High | $0.79 | $0.75 | $0.95 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |